NeuroOne Medical Technologies Corporation Royalty Expense
NeuroOne Medical Technologies Corporation (NMTC) reported Royalty Expense of $37.50 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2026-08-13
- NeuroOne Medical Technologies Corporation royalty expense for the quarter ending 2026-06-30 was $37.50K, a 0.00% change year-over-year.
- NeuroOne Medical Technologies Corporation royalty expense for the quarter ending 2026-03-31 was $37.50K, a 0.00% change year-over-year.
- NeuroOne Medical Technologies Corporation royalty expense for the quarter ending 2025-12-31 was $37.50K, a 0.00% change year-over-year.
- NeuroOne Medical Technologies Corporation royalty expense for the quarter ending 2025-09-30 was $37.50K.
- NeuroOne Medical Technologies Corporation royalty expense for fiscal 2025 was $150.00K, a 2086.27% increase from fiscal 2024.
- NeuroOne Medical Technologies Corporation royalty expense for fiscal 2024 was $6.86K, a 95.43% decline from fiscal 2023.
- NeuroOne Medical Technologies Corporation royalty expense for fiscal 2023 was $150.00K.
| Period end | Royalty Expense 3 month | Royalty Expense 6 month | Royalty Expense 9 month | Royalty Expense 12 month | Royalty Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $37.50K 10-Q · filed 2026-08-13 | $75.00K derived: sum of 2 quarters · filed 2026-08-13 | $112.50K 10-Q · filed 2026-08-13 | $150.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $37.50K 10-Q/A · filed 2026-06-12 | $75.00K 10-Q/A · filed 2026-06-12 | $112.50K derived: sum of 3 quarters · filed 2026-06-12 | $150.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $37.50K 10-Q · filed 2026-02-17 | $75.00K derived: sum of 2 quarters · filed 2026-02-17 | $112.50K derived: sum of 3 quarters · filed 2026-08-13 | $150.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-09-30 | $37.50K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $75.00K derived: sum of 2 quarters · filed 2026-08-13 | $112.50K derived: sum of 3 quarters · filed 2026-08-13 | $150.00K 10-K · filed 2025-12-17 | |
| 2025-06-30 | $37.50K 10-Q · filed 2026-08-13 | $75.00K derived: sum of 2 quarters · filed 2026-08-13 | $112.50K 10-Q · filed 2026-08-13 | $6.86K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $37.50K 10-Q/A · filed 2026-06-12 | $75.00K 10-Q/A · filed 2026-06-12 | -$30.64K derived: sum of 3 quarters · filed 2026-06-12 | $6.86K derived: sum of 4 quarters · filed 2026-06-12 | |
| 2024-12-31 | $37.50K 10-Q · filed 2026-02-17 | -$68.14K derived: sum of 2 quarters · filed 2026-02-17 | -$30.64K derived: sum of 3 quarters · filed 2026-02-17 | $6.86K derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-09-30 | -$105.64K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | -$68.14K derived: sum of 2 quarters · filed 2025-12-17 | -$30.64K derived: sum of 3 quarters · filed 2025-12-17 | $6.86K 10-K · filed 2025-12-17 | $150.00K 10-K · filed 2024-12-17 |
| 2024-06-30 | $37.50K 10-Q · filed 2025-08-14 | $75.00K derived: sum of 2 quarters · filed 2025-08-14 | $112.50K 10-Q · filed 2025-08-14 | $150.00K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $37.50K 10-Q · filed 2025-05-13 | $75.00K 10-Q · filed 2025-05-13 | $112.50K derived: sum of 3 quarters · filed 2025-05-13 | $150.00K derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | $37.50K 10-Q · filed 2025-02-12 | $75.00K derived: sum of 2 quarters · filed 2025-02-12 | $112.50K derived: sum of 3 quarters · filed 2025-02-12 | $150.00K derived: sum of 4 quarters · filed 2025-02-12 | |
| 2023-09-30 | $37.50K derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-17 | $75.00K derived: sum of 2 quarters · filed 2024-12-17 | $112.50K derived: sum of 3 quarters · filed 2024-12-17 | $150.00K 10-K · filed 2024-12-17 | $171.63K 10-K · filed 2023-12-15 |
| 2023-06-30 | $37.50K 10-Q · filed 2024-08-14 | $75.00K derived: sum of 2 quarters · filed 2024-08-14 | $112.50K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $37.50K 10-Q · filed 2024-05-14 | $75.00K 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | $37.50K 10-Q · filed 2024-02-13 | ||||
| 2022-06-30 | $37.50K 10-Q · filed 2022-08-11 | $75.00K derived: sum of 2 quarters · filed 2022-08-11 | $100.00K 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | $37.50K 10-Q · filed 2022-05-12 | $62.50K 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | $25.00K 10-Q · filed 2022-02-14 | ||||
| 2021-06-30 | $25.00K 10-Q · filed 2022-08-11 | $50.00K derived: sum of 2 quarters · filed 2022-08-11 | $100.00K derived: sum of 3 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $25.00K 10-Q · filed 2022-05-12 | $75.00K 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $50.00K 10-Q · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |